137 related articles for article (PubMed ID: 19521068)
1. Immunoglobulin A nephropathy in China: progress and challenges.
Cai GY; Chen XM
Am J Nephrol; 2009; 30(3):268-73. PubMed ID: 19521068
[TBL] [Abstract][Full Text] [Related]
2. Clinical course and prognostic factors of clinical early IgA nephropathy.
Shen P; He L; Huang D
Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907
[TBL] [Abstract][Full Text] [Related]
3. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients.
Shen P; He L; Li Y; Wang Y; Chan M
Nephron Clin Pract; 2007; 106(4):c157-61. PubMed ID: 17596724
[TBL] [Abstract][Full Text] [Related]
4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
5. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
6. Association of MEGSIN 2093C-2180T haplotype at the 3' untranslated region with disease severity and progression of IgA nephropathy.
Xia Y; Li Y; Du Y; Yang N; Li C; Leung JC; Lam MF; Huang W; Chen S; Maxwell PH; Lai KN; Wang Y
Nephrol Dial Transplant; 2006 Jun; 21(6):1570-4. PubMed ID: 16431886
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory agents against IgA nephropathy.
Tang SC; Leung JC; Lai KN
Adv Otorhinolaryngol; 2011; 72():45-9. PubMed ID: 21865687
[TBL] [Abstract][Full Text] [Related]
8. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions.
Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.
Wu J; Chen X; Xie Y; Yamanaka N; Shi S; Wu D; Liu S; Cai G
Nephrol Dial Transplant; 2005 Apr; 20(4):719-27. PubMed ID: 15701667
[TBL] [Abstract][Full Text] [Related]
11. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
13. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
14. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
15. Effects of co-administration of urokinase and benazepril on severe IgA nephropathy.
Chen X; Qiu Q; Tang L; Liu S; Cai G; Liu H; Xie Y
Nephrol Dial Transplant; 2004 Apr; 19(4):852-7. PubMed ID: 15031340
[TBL] [Abstract][Full Text] [Related]
16. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
Yamamoto R; Nagasawa Y; Shoji T; Inoue K; Uehata T; Kaneko T; Okada T; Yamauchi A; Tsubakihara Y; Imai E; Isaka Y; Rakugi H
Nephrol Dial Transplant; 2009 Dec; 24(12):3686-94. PubMed ID: 19420105
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and implications of isolated microscopic hematuria in asymptomatic Chinese pregnant women.
Szeto CC; To KF; Lai FM; Chow KM; Tam WH; Chung KY; Leung CB; Lui SF; Li PK; Lau TK
Nephron Clin Pract; 2007; 105(4):c147-52. PubMed ID: 17259739
[TBL] [Abstract][Full Text] [Related]
18. The pathogenetic aspects and gene polymorphisms of IgA nephropathy.
Maixnerová D; Merta M; Reiterová J; Stekrová J; Rysavá R; Obeidová H; Tesar V
Prague Med Rep; 2006; 107(2):171-88. PubMed ID: 17066738
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
20. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy.
Ding JX; Xu LX; Lv JC; Zhao MH; Zhang H; Wang HY
Clin Immunol; 2007 Dec; 125(3):268-74. PubMed ID: 17913589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
